MacCumber MW, Wykoff CC, Karcher H, Adiguzel E, et al. One-Year Real-World Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large US Cohort in the IRIS(R) Registry. Ophthalmology 2023 Apr 20:S0161-6420(23)00277.
PMID: 37086857